Dalila C Pinto | Icahn School of Medicine

Biography

Research Topics

Autism, Bioinformatics, Computational Biology, Epilepsy, Gene Expressions, Gene Regulation, Genetics, Genomics, Human Genetics and Genetic Disorders, RNA

Multi-Disciplinary Training Area

Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS], Neuroscience [NEU]

Research

For more information see the Pinto Lab website.

Education

MSc, MSc, University of Porto

PhD, University of Utrecht

Postdoctoral, Hospital for Sick Children Toronto

Publications

108

Publications

Selected Publications

Mapping the genetic landscape across 14 psychiatric disorders. Andrew D. Grotzinger, Josefin Werme, Wouter J. Peyrot, Oleksandr Frei, Christiaan de Leeuw, Lucy K. Bicks, Qiuyu Guo, Michael P. Margolis, Brandon J. Coombes, Anthony Batzler, Vanessa Pazdernik, Joanna M. Biernacka, Ole A. Andreassen, Verneri Anttila, Anders D. Børglum, Gerome Breen, Na Cai, Ditte Demontis, Howard J. Edenberg, Stephen V. Faraone, Barbara Franke, Michael J. Gandal, Joel Gelernter, Alexander S. Hatoum, John M. Hettema, Emma C. Johnson, Katherine G. Jonas, James A. Knowles, Karestan C. Koenen, Adam X. Maihofer, Travis T. Mallard, Manuel Mattheisen, Karen S. Mitchell, Benjamin M. Neale, Caroline M. Nievergelt, John I. Nurnberger, Kevin S. O’Connell, Roseann E. Peterson, Elise B. Robinson, Sandra S. Sanchez-Roige, Susan L. Santangelo, Jeremiah M. Scharf, Hreinn Stefansson, Kari Stefansson, Dan J. Stein, Niamh Mullins, Dalila Pinto, Nikolaos P. Daskalakis, David Cohen, Alison M. Goate. Nature

Defining suicidality phenotypes for genetic studies: perspectives of the Psychiatric Genomics Consortium Suicide Working Group. Sarah M.C. Colbert, Eric T. Monson, Ole A. Andreassen, Olatunde O. Ayinde, Peter B. Barr, Cosmin A. Bejan, Zuriel Ceja, Hilary Coon, Emily DiBlasi, Howard J. Edenberg, Joel Gelernter, Alexander Hatoum, Anastasia Izotova, Emma C. Johnson, Erin A. Kaufman, Henry R. Kranzler, Maria Koromina, Kelli Lehto, Woojae Myung, John I. Nurnberger, Alessandro Serretti, Jordan W. Smoller, Murray B. Stein, Clement C. Zai, Annette Erlangsen, Marie Gaine, Lourdes Martorell, Reeteka Sud, Claudio Toma, Tim B. Bigdeli, Nathan A. Kimbrel, Douglas Ruderfer, Anna R. Docherty, J. John Mann, Niamh Mullins, Lea Zillich, Zeynep Yilmaz, Naomi R. Wray, D. Blake Woodside, Stephanie H. Witt, Virginia Willour, Leanne M. Williams, David C. Whiteman, Thomas Werge, Frank Wendt, Myrna M. Weissman, Thomas W. Weickert, Dalila Pinto, René S. Kahn, Douglas M. Ruderfer. Molecular Psychiatry

Impact of common variants on brain gene expression from RNA to protein to schizophrenia risk. Qiuman Liang, Yi Jiang, Annie W. Shieh, Dan Zhou, Rui Chen, Feiran Wang, Meng Xu, Mingming Niu, Xusheng Wang, Dalila Pinto, Yue Wang, Lijun Cheng, Ramu Vadukapuram, Chunling Zhang, Kay Grennan, Gina Giase, Kevin P. White, Junmin Peng, Bingshan Li, Chunyu Liu, Chao Chen, Sidney H. Wang. Nature Communications

View All Publications

Office Locations

Hess CSM Building Floor 8 Room 302 (lab)

1470 Madison Ave

New York, NY 10029

Hess Center for Science and Medicine

1470 Madison Av, 8th floor, room 115 (office)

New York, NY 10029

212-824-8943

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Pinto has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Pinto has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.